ambrisentan aop 10 mg tabletti, kalvopäällysteinen
aop orphan pharmaceuticals gmbh - ambrisentan - tabletti, kalvopäällysteinen - 10 mg - ambrisentaani
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - neuromuskulaarisen salpauksen aiheuttama rokuronin tai vekuronin. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
vetergesic vet 0.3 mg/ml injektioneste, liuos
ceva santÉ animale - buprenorphine hydrochloride - injektioneste, liuos - 0.3 mg/ml - buprenorfiini
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroxysmal - immunosuppressantit - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
filsuvez
amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - valmisteet haavojen ja haavaumien hoitoon - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.
palladon 4 mg depotkapseli, kova
mundipharma oy - hydromorphone hydrochloride - depotkapseli, kova - 4 mg - hydromorfoni
palladon 8 mg depotkapseli, kova
mundipharma oy - hydromorphone hydrochloride - depotkapseli, kova - 8 mg - hydromorfoni
palladon 16 mg depotkapseli, kova
mundipharma oy - hydromorphone hydrochloride - depotkapseli, kova - 16 mg - hydromorfoni
palladon 24 mg depotkapseli, kova
mundipharma oy - hydromorphone hydrochloride - depotkapseli, kova - 24 mg - hydromorfoni
palladon 1.3 mg kapseli, kova
mundipharma oy - hydromorphone hydrochloride - kapseli, kova - 1.3 mg - hydromorfoni